tiprankstipranks
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
Holding NKTR?
Track your performance easily

Nektar Therapeutics (NKTR) Financial Statements

1,229 Followers

Nektar Therapeutics Financial Overview

Nektar Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.837; its P/E ratio is -1.21; Nektar Therapeutics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 24.12M$ 23.49M$ 21.64M$ 23.89M$ 24.14M
Gross Profit$ 19.69M$ 13.75M$ 13.11M$ 16.60M$ 11.71M
EBIT$ -37.05M$ -52.32M$ -31.31M$ -35.24M$ -39.99M
EBITDA$ -36.05M$ -50.86M$ -29.70M$ -33.59M$ -38.29M
Net Income Common Stockholders$ -37.06M$ -52.36M$ -36.80M$ -42.08M$ -45.84M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 244.50M$ 271.24M$ 289.24M$ 303.62M$ 372.66M
Total Assets$ 307.97M$ 343.33M$ 396.01M$ 398.03M$ 442.24M
Total Debt$ 108.26M$ 112.10M$ 114.08M$ 117.78M$ 121.29M
Net Debt$ -136.23M$ -159.13M$ -175.16M$ -185.84M$ -251.37M
Total Liabilities$ 259.08M$ 263.65M$ 269.31M$ 267.05M$ 282.88M
Stockholders Equity$ 48.88M$ 79.69M$ 126.70M$ 130.99M$ 159.37M
Cash Flow-
Free Cash Flow$ -44.60M$ -37.89M$ -48.05M$ -47.28M$ -42.15M
Operating Cash Flow$ -43.93M$ -37.70M$ -47.89M$ -47.05M$ -42.12M
Investing Cash Flow$ 46.12M$ 16.98M$ 19.26M$ 17.38M$ 56.41M
Financing Cash Flow$ 13.00K$ 19.00K$ 42.00M$ 12.00K-
Currency in USD

Nektar Therapeutics Earnings and Revenue History

Nektar Therapeutics Debt to Assets

Nektar Therapeutics Cash Flow

Nektar Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis